Bluejay Diagnostics financials
$0.9390−2.18%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q2 '26 Jun 30 | Q1 '26 Mar 31 | Q4 '25 Dec 31 | Q3 '25 Sep 30 | Q2 '25 Jun 30 | Q1 '25 Mar 31 | Q4 '24 Dec 31 | Q3 '24 Sep 30 | Q2 '24 Jun 30 | Q1 '24 Mar 31 | Q4 '23 Dec 31 | Q3 '23 Sep 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Gross profit | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Gross margin | — | — | — | — | — | — | — | — | — | — | — | — |
| Operating income | -$2.3M | -$1.9M | -$1.5M | -$1.6M | -$2.0M | -$1.9M | -$1.5M | -$1.4M | -$1.9M | -$2.4M | -$2.4M | -$2.3M |
| Net income | -$2.3M | -$1.9M | -$1.4M | -$1.6M | -$2.0M | -$1.9M | -$1.4M | -$14.7M | -$2.5M | -$2.3M | -$2.3M | -$2.3M |
| Net margin | — | — | — | — | — | — | — | — | — | — | — | — |
| Diluted EPS | $-1.12 | $-1.95 | — | $-4.04 | $-5.64 | $-13.46 | $-111.26 | $-307.76 | $-1024.64 | $-1579.04 | $-1187.94 | $-3334.00 |
| EBITDA | -$2.3M | -$1.9M | -$1.4M | -$1.6M | -$2.0M | -$1.9M | -$1.5M | -$1.3M | -$1.9M | -$2.4M | -$2.4M | -$2.1M |
| Operating cash flow | -$1.5M | -$1.6M | -$1.5M | -$1.4M | -$2.1M | -$1.2M | -$1.5M | -$2.2M | -$1.9M | -$2.3M | -$2.8M | -$1.1M |
| Free cash flow | -$1.6M | -$1.6M | -$1.6M | -$1.4M | -$2.1M | -$1.2M | -$1.5M | -$2.2M | -$2.2M | -$2.3M | -$2.9M | -$1.2M |
| Diluted shares | 2.1M | 1.0M | — | 0.4M | 0.3M | 0.1M | 0.1M | 0.0M | 0.0M | 0.0M | 0.0M | 0.0M |
Balance sheet
| Period end | Jun 30 | Mar 31 | Dec 31 | Sep 30 | Jun 30 | Mar 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $9.6M | $3.7M | $5.2M | $3.1M | $4.4M | $3.1M |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total debt | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total assets | $11.5M | $5.6M | $7.1M | $4.9M | $6.4M | $5.3M |
| Total liabilities | $2.1M | $1.4M | $1.1M | $1.2M | $1.1M | $1.4M |
| Shareholders' equity | $9.4M | $4.2M | $6.0M | $3.7M | $5.3M | $3.9M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology